V022-6885 Screening compound: [3-(benzyloxy)-2-hydroxypropyl](cyclopropylmethyl){[5-(3-fluorophenoxy)-1-methyl-3-phenyl-1H-pyrazol-4-yl]methyl}amine

V022-6885 Screening compound: [3-(benzyloxy)-2-hydroxypropyl](cyclopropylmethyl){[5-(3-fluorophenoxy)-1-methyl-3-phenyl-1H-pyrazol-4-yl]methyl}amine
V022-6885 Screening compound: [3-(benzyloxy)-2-hydroxypropyl](cyclopropylmethyl){[5-(3-fluorophenoxy)-1-methyl-3-phenyl-1H-pyrazol-4-yl]methyl}amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-6885
[3-(benzyloxy)-2-hydroxypropyl](cyclopropylmethyl){[5-(3-fluorophenoxy)-1-methyl-3-phenyl-1H-pyrazol-4-yl]methyl}amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-6885

Molecular Formula

C31H34FN3O3 (C31 H34 FN3 O3)

Compound Name

[3-(benzyloxy)-2-hydroxypropyl](cyclopropylmethyl){[5-(3-fluorophenoxy)-1-methyl-3-phenyl-1H-pyrazol-4-yl]methyl}amine

IUPAC name

[3-(benzyloxy)-2-hydroxypropyl](cyclopropylmethyl){[5-(3-fluorophenoxy)-1-methyl-3-phenyl-1H-pyrazol-4-yl]methyl}amine

SMILES

Cn(c(Oc1cccc(F)c1)c1CN(CC(COCc2ccccc2)O)CC2CC2)nc1-c1ccccc1

InChI

InChI=1S/C31H34FN3O3/c1-34-31(38-28-14-8-13-26(32)17-28)29(30(33-34)25-11-6-3-7-12-25)20-35(18-23-15-16-23)19-27(36)22-37-21-24-9-4-2-5-10-24/h2-14,17,23,27,36H,15-16,18-22H2,1H3/t27-/m0/s1

InChI Key

IXQVZYSKMBTJRB-MHZLTWQESA-N

MDL Number (MFCD)

MFCD19881952

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

515.63

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.387

Distribution Coefficient, logD

1.880

Water Solubility, LogSw

-5.54

Polar Surface Area

50.281

Acid Dissociation Constant (pKa)

14.75

Base Dissociation Constant (pKb)

10.91

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.30

V022-6885 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V022-6885 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-6885?
Check Price and Availability of V022-6885, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-6885 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-6885
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-6885
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-6885 available by request